Portside Wealth Group LLC bought a new position in shares of Stevanato Group S.p.A. (NYSE:STVN – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 10,179 shares of the company’s stock, valued at approximately $249,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Twin Tree Management LP acquired a new position in Stevanato Group in the first quarter valued at approximately $29,000. SVB Wealth LLC purchased a new stake in shares of Stevanato Group during the 1st quarter worth approximately $46,000. Van Berkom & Associates Inc. boosted its holdings in shares of Stevanato Group by 33.3% in the 1st quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company’s stock valued at $49,000 after buying an additional 600 shares in the last quarter. First Horizon Advisors Inc. boosted its holdings in shares of Stevanato Group by 14.9% in the 2nd quarter. First Horizon Advisors Inc. now owns 3,833 shares of the company’s stock valued at $94,000 after buying an additional 497 shares in the last quarter. Finally, Hilltop National Bank purchased a new position in shares of Stevanato Group in the 2nd quarter valued at $158,000.
Stevanato Group Price Performance
Shares of NYSE:STVN opened at €21.19 on Friday. Stevanato Group S.p.A. has a one year low of €17.81 and a one year high of €28.00. The stock has a market capitalization of $6.42 billion, a price-to-earnings ratio of 37.17, a PEG ratio of 2.09 and a beta of 0.56. The company has a 50-day simple moving average of €24.98 and a 200-day simple moving average of €24.27. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.30 and a current ratio of 1.89.
Analyst Ratings Changes
View Our Latest Report on STVN
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Articles
- Five stocks we like better than Stevanato Group
- How to Most Effectively Use the MarketBeat Earnings Screener
- Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Peter Thiel Dumps NVIDIA and Slashes Tesla Stake—Is the AI Bubble About to Pop?
- Why Are Stock Sectors Important to Successful Investing?
- Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
